Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

    Forecasted

    This grant funds the further development and maintenance of advanced informatics tools that support all stages of cancer research, from biology to prevention, under the NCI’s ITCR Program.

    Browse similar grants
    Cancer Research Grants 2026AI in Healthcare Research Grants
    OverviewSimilar Grants
    OverviewSimilar Grants

    Forecast to Publish a Funding Opportunity Announcement for Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to support and sustain widely-used informatics tools that advance cancer research, emphasizing ongoing impact, user support, and community engagement.

    HHS-NIH11Due Oct 19, 2026· 1d$600,000

    Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.

    HHS-NIH11Due Oct 19, 2027$300,000

    Forecast to Publish a Funding Opportunity Announcement for Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to enhance and advance emerging informatics technologies that improve data use across cancer research, emphasizing user engagement, innovation, and impact.

    HHS-NIH11Due Oct 19, 2026· 1d$600,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026$150,000